Your browser doesn't support javascript.
loading
ADHD Prevalence Among U.S. Children and Adolescents in 2022: Diagnosis, Severity, Co-Occurring Disorders, and Treatment.
Danielson, Melissa L; Claussen, Angelika H; Bitsko, Rebecca H; Katz, Samuel M; Newsome, Kimberly; Blumberg, Stephen J; Kogan, Michael D; Ghandour, Reem.
Afiliação
  • Danielson ML; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
  • Claussen AH; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
  • Bitsko RH; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
  • Katz SM; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
  • Newsome K; Oak Ridge Institute for Science and Education.
  • Blumberg SJ; National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention.
  • Kogan MD; National Center for Health Statistics, Centers for Disease Control and Prevention.
  • Ghandour R; Maternal and Child Health Bureau, Health Resources and Services Administration.
J Clin Child Adolesc Psychol ; 53(3): 343-360, 2024.
Article em En | MEDLINE | ID: mdl-38778436
ABSTRACT

OBJECTIVE:

To provide updated national prevalence estimates of diagnosed attention-deficit/hyperactivity disorder (ADHD), ADHD severity, co-occurring disorders, and receipt of ADHD medication and behavioral treatment among U.S. children and adolescents by demographic and clinical subgroups using data from the 2022 National Survey of Children's Health (NSCH).

METHOD:

This study used 2022 NSCH data to estimate the prevalence of ever diagnosed and current ADHD among U.S. children aged 3-17 years. Among children with current ADHD, ADHD severity, presence of current co-occurring disorders, and receipt of medication and behavioral treatment were estimated. Weighted estimates were calculated overall and for demographic and clinical subgroups (n = 45,169).

RESULTS:

Approximately 1 in 9 U.S. children have ever received an ADHD diagnosis (11.4%, 7.1 million children) and 10.5% (6.5 million) had current ADHD. Among children with current ADHD, 58.1% had moderate or severe ADHD, 77.9% had at least one co-occurring disorder, approximately half of children with current ADHD (53.6%) received ADHD medication, and 44.4% had received behavioral treatment for ADHD in the past year; nearly one third (30.1%) did not receive any ADHD-specific treatment.

CONCLUSIONS:

Pediatric ADHD remains an ongoing and expanding public health concern, as approximately 1 million more children had ever received an ADHD diagnosis in 2022 than in 2016. Estimates from the 2022 NSCH provide information on pediatric ADHD during the last full year of the COVID-19 pandemic and can be used by policymakers, government agencies, health care systems, public health practitioners, and other partners to plan for needs of children with ADHD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Índice de Gravidade de Doença / Comorbidade Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Deficit de Atenção com Hiperatividade / Índice de Gravidade de Doença / Comorbidade Limite: Adolescent / Child / Child, preschool / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article